Pulmatrix and Cullgen Announce Proposed Merger
2024-11-13

Pulmatrix and Cullgen Announce Proposed Merger

Pulmatrix and Cullgen have announced a merger to form a Nasdaq-listed entity, focusing on targeted protein degradation
BioNTech to Acquire China’s Biotheus for USD800 Million
2024-11-13

BioNTech to Acquire China’s Biotheus for USD800 Million

BioNTech has reached an agreement to acquire Chinese biopharmaceutical company Biotheus for $800 million
HLC Brings Healthcare Portfolio Companies to Southeast Asia
2024-11-12

HLC Brings Healthcare Portfolio Companies to Southeast Asia

HLC team, along with our portfolio companies and ecosystem partners, embarked on a 5-day business development trip to Thailand and Indonesia.
HighLight Capital invests in ITM
2024-10-08

HighLight Capital invests in ITM

HLC invests in ITM to support ITM's radiopharmaceutical pipeline and to strengthen its leading position in medical radioisotope manufacturing. 
HLC Achieves Top Rankings in Preqin
2024-09-18

HLC Achieves Top Rankings in Preqin

HighLight Capital achieves outstanding performance in net IRR and DPI.
HLC Ranks Top 20 in the HEC Paris – Dow Jones 2023 Growth Capital Performance Ranking
2024-05-09

HLC Ranks Top 20 in the HEC Paris – Dow Jones 2023 Growth Capital Performance Ranking

HLC ranked as Top 20 and was one of the only three Asian firm that entered the list.
  • 1
  • 2
  • 3
  • 4
  • 5
  • 31 records in total